L-citrulline/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases flow-mediated dilation
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×3“FMD improved in the fasted state after CIT supplementation compared to placebo (CIT: Δ1.3 ± 0.2% vs. Placebo: Δ−0.5 ± 0.1%, p < 0.01) A).”
Quoted verbatim from Effects of L-Citrulline Supplementation on Endothelial Function, Arterial Stiffness, and Blood Glucose Level in the Fasted and Acute Hyperglycemic States in Middle-Aged and Older Adults with Type 2 Diabetes.. - Study
- crossover
- Participants
- 16
- Duration
- 4 weeks
- Dose
- 6 g/day L-citrulline as 750 mg capsules, four in the morning and four in the evening, for 4 weeks
- Population
- Middle-aged and older adults with type 2 diabetes, mean age 62 years, treated with oral hypoglycaemic drugs and/or insulin, none doing structured exercise; measured in the fasted state.
Effects of L-Citrulline Supplementation on Endothelial Function, Arterial Stiffness, and Blood Glucose Level in the Fasted and Acute Hyperglycemic States in Middle-Aged and Older Adults with Type 2 Diabetes.2025PMID:41374029Permalink
Keep reading
- Everything the graph holds on L-citrulline
- Every compound studied against Flow-mediated dilation
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M12Q1PQ217JFHB8NRPY0R3PD